Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100562 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100565 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-03-26 | 2020-04-02 | 109589 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-08 | 110716 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-09 | 110719 |
| TEVA-CINACALCET | 30MG | TABLET | Resolved | 2020-07-23 | 2021-03-18 | 120902 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-01 | 2020-10-30 | 125467 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-10-30 | 2021-03-18 | 127613 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-11-27 | 2020-12-17 | 129039 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-03-25 | 2021-06-03 | 136295 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-04-21 | 2021-07-29 | 137885 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-08-05 | 2021-09-30 | 143728 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-27 | 2023-07-05 | 144747 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-09-02 | 2021-12-02 | 145106 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-09 | 2021-12-08 | 145446 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-16 | 2021-11-11 | 145791 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147714 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |